106 related articles for article (PubMed ID: 31342957)
1. The effect of bupropion augmentation of minocycline in the treatment of depression.
Bendale M; DSouza SR; Addepalli V; Kale PP
Acta Neurobiol Exp (Wars); 2019; 79(2):217-224. PubMed ID: 31342957
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of antidepressant effects of duloxetine and bupropion by caffeine in mice.
Kale PP; Addepalli V
Pharmacol Biochem Behav; 2014 Sep; 124():238-44. PubMed ID: 24933334
[TBL] [Abstract][Full Text] [Related]
3. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
Dhir A; Kulkarni SK
Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
[TBL] [Abstract][Full Text] [Related]
4. Novel antagonists of 5-HT
Partyka A; Jastrzębska-Więsek M; Antkiewicz-Michaluk L; Michaluk J; Wąsik A; Canale V; Zajdel P; Kołaczkowski M; Wesołowska A
Behav Brain Res; 2019 Feb; 359():9-16. PubMed ID: 30312638
[TBL] [Abstract][Full Text] [Related]
5. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice.
Nadar JS; Kale PP; Kadu PK; Prabhavalkar K; Dhangar R
Neurol Res Int; 2018; 2018():9828639. PubMed ID: 30510800
[TBL] [Abstract][Full Text] [Related]
7. Effects of lobeline and reboxetine, fluoxetine, or bupropion combination on depression-like behaviors in mice.
Roni MA; Rahman S
Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):1-6. PubMed ID: 26455278
[TBL] [Abstract][Full Text] [Related]
8. Minocycline produced antidepressant-like effects on the learned helplessness rats with alterations in levels of monoamine in the amygdala and no changes in BDNF levels in the hippocampus at baseline.
Arakawa S; Shirayama Y; Fujita Y; Ishima T; Horio M; Muneoka K; Iyo M; Hashimoto K
Pharmacol Biochem Behav; 2012 Jan; 100(3):601-6. PubMed ID: 21967886
[TBL] [Abstract][Full Text] [Related]
9. Bupropion: a review of its mechanism of antidepressant activity.
Ascher JA; Cole JO; Colin JN; Feighner JP; Ferris RM; Fibiger HC; Golden RN; Martin P; Potter WZ; Richelson E
J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2007 Aug; 569(1-2):77-83. PubMed ID: 17585901
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like actions of minocycline combined with several glutamate antagonists.
Molina-Hernández M; Tellez-Alcántara NP; Pérez-García J; Olivera-Lopez JI; Jaramillo-Jaimes MT
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):380-6. PubMed ID: 17933448
[TBL] [Abstract][Full Text] [Related]
12. Influence of the selective antagonist of the NR2B subunit of the NMDA receptor, traxoprodil, on the antidepressant-like activity of desipramine, paroxetine, milnacipran, and bupropion in mice.
Stasiuk W; Szopa A; Serefko A; Wyska E; Świąder K; Dudka J; Wlaź P; Poleszak E
J Neural Transm (Vienna); 2017 Mar; 124(3):387-396. PubMed ID: 27900470
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
Dhir A; Malik S; Kessar SV; Singh KN; Kulkarni SK
Eur Neuropsychopharmacol; 2011 Sep; 21(9):705-14. PubMed ID: 21277753
[TBL] [Abstract][Full Text] [Related]
14. Possible involvement of sigma-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor.
Dhir A; Kulkarni SK
Fundam Clin Pharmacol; 2008 Aug; 22(4):387-94. PubMed ID: 18705749
[TBL] [Abstract][Full Text] [Related]
15. On the effect of minocycline on the depressive-like behavior of mice repeatedly exposed to malathion: interaction between nitric oxide and cholinergic system.
Saeedi Saravi SS; Amirkhanloo R; Arefidoust A; Yaftian R; Saeedi Saravi SS; Shokrzadeh M; Dehpour AR
Metab Brain Dis; 2016 Jun; 31(3):549-61. PubMed ID: 26581675
[TBL] [Abstract][Full Text] [Related]
16. Minocycline prevents depression-like behavior in streptozotocin-induced diabetic mice.
Sakurai M; Iwasa R; Sakai Y; Morimoto M
Neuropathology; 2021 Apr; 41(2):109-117. PubMed ID: 33230848
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-like effect of the extracted of Kai Xin San, a traditional Chinese herbal prescription, is explained by modulation of the central monoaminergic neurotransmitter system in mouse.
Zhou XJ; Liu M; Yan JJ; Cao Y; Liu P
J Ethnopharmacol; 2012 Jan; 139(2):422-8. PubMed ID: 22138350
[TBL] [Abstract][Full Text] [Related]
18. Lycopene alleviates BCG-induced depressive phenotypes in mice by disrupting 5-HT3 receptor - IDO1 interplay in the brain.
Deore R; Ansari R; Awathale SN; Shelke M; Badwaik HR; Goyal SN; Nakhate KT
Eur J Pharmacol; 2024 Aug; 977():176707. PubMed ID: 38830456
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the dopaminergic and serotonergic systems in the antidepressant-like effect caused by 4-phenyl-1-(phenylselanylmethyl)-1,2,3-triazole.
Donato F; de Gomes MG; Goes AT; Seus N; Alves D; Jesse CR; Savegnago L
Life Sci; 2013 Sep; 93(9-11):393-400. PubMed ID: 23911670
[TBL] [Abstract][Full Text] [Related]
20. Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.
Jastrzębska-Więsek M; Siwek A; Partyka A; Antkiewicz-Michaluk L; Michaluk J; Romańska I; Kołaczkowski M; Wesołowska A
Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):839-49. PubMed ID: 27106213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
